ArticleJHEP reports : innovation in hepatology2026
Elexacaftor-tezacaftor-ivacaftor and cystic fibrosis liver disease: A turning point that calls for cautious optimism.
Pierre-Emmanuel Rautou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.